SARA ZUCHOWSKI: Open Payments
NPI 1992817266 · WESTLAKE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 25 payments from 7 companies in 2025. Trend: 2023 $785 · 2024 $479 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $178 |
| Lundbeck LLC | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $13 |
Products named: VRAYLAR, REXULTI, TRINTELLIX, Qelbree, INGREZZA.
Industry payments across OH — which companies pay providers there.
